FORM OF -------Underwriting Agreement • November 7th, 2001 • Icos Corp / De • Pharmaceutical preparations • New York
andIndenture • August 5th, 2003 • Icos Corp / De • Pharmaceutical preparations • New York
Exhibit 4.1 RIGHTS AGREEMENT Dated as of August 9, 2002Rights Agreement • August 9th, 2002 • Icos Corp / De • Pharmaceutical preparations • New York
REDACTED VERSION ---------------- EXHIBIT 10.22 TOLicense Agreement • March 31st, 1997 • Icos Corp / De • Pharmaceutical preparations • Delaware
EXHIBIT 10.21 ICOS SERVICES AGREEMENTServices Agreement • March 31st, 1997 • Icos Corp / De • Pharmaceutical preparations • Delaware
EXHIBIT 10.13 This FIRST AMENDMENT TO LEASE (this "Amendment") is made this 5th day of August, 1997, by and between WRC PROPERTIES, INC. ("Landlord") and ICOS CORPORATION ("Tenant").Lease • March 13th, 2003 • Icos Corp / De • Pharmaceutical preparations
EXHIBIT 10.1 TOLimited Liability Company Agreement • November 13th, 1998 • Icos Corp / De • Pharmaceutical preparations • Delaware
EXHIBIT 10.1 AGREEMENT OF LIMITED PARTNERSHIPLimited Partnership Agreement • August 14th, 2000 • Icos Corp / De • Pharmaceutical preparations • Delaware
EXHIBIT 10.18 TOShareholders' Agreement • March 31st, 1997 • Icos Corp / De • Pharmaceutical preparations • Delaware
INDENTUREIndenture • July 13th, 2001 • Icos Corp / De • Pharmaceutical preparations • New York
CONTENTSLease Agreement • March 31st, 1999 • Icos Corp / De • Pharmaceutical preparations
BETWEENLease Amendment • March 13th, 2003 • Icos Corp / De • Pharmaceutical preparations
EXHIBIT 10.23 LEASE AGREEMENT BY AND BETWEEN BELLEVUE TRADE CENTER, LLC, A WASHINGTON LIMITED LIABILITY COMPANY ("LANDLORD")Lease Agreement • March 13th, 2003 • Icos Corp / De • Pharmaceutical preparations • Washington
EXHIBIT 10.2 TOLicense Agreement • November 13th, 1998 • Icos Corp / De • Pharmaceutical preparations • Delaware
Exhibit 4.2 ICOS CORPORATION 2% Convertible Subordinated Notes due July 1, 2023 REGISTRATION RIGHTS AGREEMENT -----------------------------Registration Rights Agreement • August 5th, 2003 • Icos Corp / De • Pharmaceutical preparations • New York
AMENDMENT TO COLLABORATION AGREEMENT BETWEEN GLAXO GROUP LIMITED GLAXO WELLCOME INC. (f/k/a GLAXO INC) AND ICOS CORPORATIONCollaboration Agreement • March 31st, 1997 • Icos Corp / De • Pharmaceutical preparations
INDENTUREIndenture • July 13th, 2001 • Icos Corp / De • Pharmaceutical preparations • New York
EXHIBIT 10.22 INDUSTRIAL LEASE - SINGLE TENANT THIS LEASE AGREEMENT made this 4th day of June, 2001, by and between BENAROYA CAPITAL COMPANY, LLC, a Washington limited liability company (the "Lessor") and ICOS CORPORATION, a Delaware corporation (the...Industrial Lease • March 13th, 2003 • Icos Corp / De • Pharmaceutical preparations • Washington
REDACTED VERSION ---------------- EXHIBIT 10.20 TODevelopment and Supply Agreement • March 31st, 1997 • Icos Corp / De • Pharmaceutical preparations • Delaware
TOLimited Partnership Agreement • August 26th, 1997 • Icos Corp / De • Pharmaceutical preparations • Delaware
EXHIBIT 10.1 DEVELOPMENT AND MARKETING COLLABORATION AGREEMENTDevelopment and Marketing Collaboration Agreement • August 14th, 2001 • Icos Corp / De • Pharmaceutical preparations • New York
ARTICLE 1 DEFINITIONSResearch and Development Service Agreement • August 14th, 2000 • Icos Corp / De • Pharmaceutical preparations • Delaware
ICOS CORPORATION AMENDED AND RESTATED CHANGE IN CONTROL SEVERANCE AGREEMENTChange in Control Severance Agreement • October 20th, 2006 • Icos Corp • Pharmaceutical preparations • Washington
THIS AMENDED AND RESTATED CHANGE IN CONTROL SEVERANCE AGREEMENT, (the “Agreement”) is entered into pursuant to the ICOS Corporation Change in Control Severance Plan (the “Plan”) effective as of , 2006, (the “Effective Date”), by and between [OFFICER] (the “Employee”) and ICOS Corporation, a Washington corporation, (the “Company”). This Agreement and the Plan provide the complete terms and conditions of the Employee’s participation in the Plan and this Agreement supersedes all prior agreements with respect to the Employee’s participation in the Plan. The Plan and this Agreement constitute the Summary Plan Description required under the Employee Retirement Income Security Act of 1974, as amended (“ERISA”).
EXHIBIT 10.1 INDUSTRIAL REAL ESTATE LEASE ARTICLE ONE: BASIC TERMS This Article One contains the Basic Terms of this Lease between the Landlord and Tenant named below. Other Articles, Sections and Paragraphs of the Lease referred to in this Article...Industrial Real Estate Lease • November 17th, 1997 • Icos Corp / De • Pharmaceutical preparations
EXHIBIT 1.1 5,000,000Underwriting Agreement • November 15th, 2000 • Icos Corp / De • Pharmaceutical preparations • New York
RECITALSFormation and Performance Agreement • August 14th, 2000 • Icos Corp / De • Pharmaceutical preparations • Texas
RECITALSEndothelin License Agreement • August 14th, 2000 • Icos Corp / De • Pharmaceutical preparations • Delaware
ICOS CORPORATIONIncentive Stock Option Agreement • August 4th, 2005 • Icos Corp / De • Pharmaceutical preparations
ICOS Corporation, a Delaware corporation (the “Company”), hereby grants an Option to purchase shares of its common stock (the “Shares”) to the Optionee named below. The terms and conditions of the Option are set forth in this cover sheet, in the attachment and in the Company’s 1999 Long-Term Incentive Plan (the “Plan”).
ICOS CORPORATIONNonstatutory Stock Option Agreement • August 4th, 2005 • Icos Corp / De • Pharmaceutical preparations
ICOS Corporation, a Delaware corporation (the “Company”), hereby grants an Option to purchase shares of its common stock (the “Shares”) to the Optionee named below. The terms and conditions of the Option are set forth in this cover sheet, in the attachment and in the Company’s 1999 Long-Term Incentive Plan (the “Plan”).
ICOS CORPORATION CHANGE IN CONTROL SEVERANCE AGREEMENTChange in Control Severance Agreement • July 25th, 2005 • Icos Corp / De • Pharmaceutical preparations • Washington
THIS CHANGE IN CONTROL SEVERANCE AGREEMENT (the “Agreement”) is entered into pursuant to the ICOS Corporation Change in Control Severance Plan (the “Plan”) as of July 19, 2005, (the “Effective Date”), by and between (the “Employee”) and ICOS Corporation, a Delaware corporation, (the “Company”). The Plan and this Agreement constitute the Summary Plan Description required under the Employee Retirement Income Security Act of 1974, as amended (“ERISA”).
FIRST LEASE AMENDMENT Between BENAROYA CAPITAL COMPANY, LLC and ICOS CORPORATIONLease Amendment • November 3rd, 2005 • Icos Corp • Pharmaceutical preparations
This First Lease Amendment dated May 9, 2005 is attached to and made part of that certain Lease dated September 6, 2000, (the “Lease”) between Benaroya Capital Company, LLC., a Washington limited liability company, as Lessor (“Lessor”) and ICOS Corporation, a Delaware corporation, as Lessee (“Lessee”) in the Building known as Canyon Park – 4, at 2222 220th Street SE in Bothell, Washington (the “Premises”). The Premises are more particularly described in the Lease.
EXHIBIT 10.3 TOProduct Development Agreement • August 26th, 1997 • Icos Corp / De • Pharmaceutical preparations • New York
EXHIBIT 10.3 TOPde5 License Agreement • November 13th, 1998 • Icos Corp / De • Pharmaceutical preparations • Delaware
ICOS CORPORATIONStock Grant Agreement • December 15th, 2005 • Icos Corp • Pharmaceutical preparations
ICOS Corporation, a Washington corporation (the “Company”), hereby awards shares of Common Stock to the Participant named below. The terms and conditions of the Award are set forth in this cover sheet, in the attached Stock Grant Agreement, in the Equity Award Program for Non-Employee Directors and in the ICOS Corporation 1999 Long-Term Incentive Plan (the “Plan”).
ICOS CORPORATION RESTRICTED STOCK AWARD AGREEMENTRestricted Stock Award Agreement • August 14th, 2002 • Icos Corp / De • Pharmaceutical preparations • Washington
